N2004-04: Fenretinide LXS in Treating Patients With Recurrent, Refractory, or Persistent Neuroblastoma
Children's Hospital Los Angeles
Children's Hospital Los Angeles
South Plains Oncology Consortium
Celgene
Montefiore Medical Center
AbbVie
GlaxoSmithKline
Takeda
National Cancer Institute (NCI)
Seagen Inc.
Eisai Inc.
Roswell Park Cancer Institute
Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal
Abbott
Bristol-Myers Squibb
Abbott